journal article·2005-05Open access

Entrapment ability and release profile of corticosteroids from starch‐based microparticles

G. A. Silva, F. J. Costa, N. M. Neves, O. P. Coutinho, A. C. P. Dias, R. L. Reis

Abstract

Abstract We previously described the synthesis of starch‐based microparticles that were shown to be bioactive (when combined with Bioactive Glass 45S5) and noncytotoxic. To further assess their potential for biomedical applications such as controlled release, three corticosteroids with a similar basic structure—dexamethasone (DEX), 16α‐methylprednisonole (MP), and 16α‐methylprednisolone acetate (MPA)—were used as models for the entrapment and release of bioactive agents. DEX, MP, and MPA were entrapped into starch‐based microparticles at 10% wt/wt of the starch‐based polymer and the loading efficiencies, as well as the release profiles, were evaluated. Differences were found for the loading efficiencies of the three corticosteroids, with DEX and MPA being the most successfully loaded (82 and 84%, respectively), followed by MP (51%). These differences might be explained based on the differential distribution of the molecules within the matrix of the microparticles. Furthermore, a differential burst release was observed in the first 24 h for all corticosteroids with DEX and MP being more pronounced (around 25%), whereas only 12% of MPA was released during the same time period. Whereas the water uptake profile can account for this first stage burst release, the subsequent slower release stage was mainly attributed to degradation of the microparticle network. Differences in the release profiles can be explained based on the structure of the molecule, because MPA, a more bulky and hydrophobic molecule, is released at a slower rate compared with DEX and MP. In this work, it is shown that these carriers were able to sustain a controlled release of the entrapped corticosteroids over 30 days, which confirms the potential of these systems to be used as carriers for the delivery of bioactive agents. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res 73A: 234–243, 2005
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems · biodegradable polymer synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. 10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P ↗
2. 10.1007/BF0013431810.1007/BF00134318 ↗
3. 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-110.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1 ↗
4. 10.1002/(SICI)1097-0126(199708)43:4<347::AID-PI764>3.0.CO;2-C10.1002/(SICI)1097-0126(199708)43:4<347::AID-PI764>3.0.CO;2-C ↗
5. Using nonconventional processing to develop anisotropic and biodegradable composites of starch‐based thermoplastics reinforced with bone‐like ceramics
6. 10.1016/S0142-9612(00)00211-810.1016/S0142-9612(00)00211-8 ↗
7. 10.1023/A:102201571217010.1023/A:1022015712170 ↗
8. 10.1002/pen.1101010.1002/pen.11010 ↗
9. 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-110.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1 ↗
10. SousaRA ReisRL CunhaAM BevisMJ.Structure and properties of hydroxylapatite reinforced starch bone‐analogue composites. In: Proceedings from the Bioceramics 13 Meeting.2000. p.669–672.10.4028/www.scientific.net/KEM.192-195.669 ↗
11. 10.1002/pen.1101010.1002/pen.11010 ↗
12. 10.1007/978-1-4419-9240-6_1610.1007/978-1-4419-9240-6_16 ↗
13. 10.1016/S0142-9612(01)00322-210.1016/S0142-9612(01)00322-2 ↗
14. 10.1023/A:100894412797110.1023/A:1008944127971 ↗
15. 10.1163/15685620175339576110.1163/156856201753395761 ↗
16. 10.1016/S0142-9612(01)00322-210.1016/S0142-9612(01)00322-2 ↗
17. 10.1016/S0266-3538(02)00213-010.1016/S0266-3538(02)00213-0 ↗
18. 10.1023/A:102329461586610.1023/A:1023294615866 ↗
19. 10.1016/S0928-4931(02)00008-510.1016/S0928-4931(02)00008-5 ↗
20. 10.1016/S0142-9612(00)00395-110.1016/S0142-9612(00)00395-1 ↗
21. 10.1016/S0142-9612(00)00377-X10.1016/S0142-9612(00)00377-X ↗
22. 10.1016/S0928-4931(02)00009-710.1016/S0928-4931(02)00009-7 ↗
23. 10.1016/S0142-9612(01)00272-110.1016/S0142-9612(01)00272-1 ↗
24. 10.1002/jbm.a.1007510.1002/jbm.a.10075 ↗
25. 10.1089/1076327036069700310.1089/10763270360697003 ↗
26. 10.1023/A:102321491859210.1023/A:1023214918592 ↗
27. 10.1021/bm030039710.1021/bm0300397 ↗
28. 10.1023/A:100890042832510.1023/A:1008900428325 ↗
29. 10.1023/A:101851410766910.1023/A:1018514107669 ↗
30. 10.1002/jbm.a.3009910.1002/jbm.a.30099 ↗
31. 10.1016/S0169-409X(98)00038-610.1016/S0169-409X(98)00038-6 ↗
32. Drug delivery systems10.1557/S0883769400056050 ↗
33. 10.1016/S0960-8966(02)00180-310.1016/S0960-8966(02)00180-3 ↗
34. 10.1016/S0168-3659(97)00212-510.1016/S0168-3659(97)00212-5 ↗
35. 10.1016/S0939-6411(00)00107-710.1016/S0939-6411(00)00107-7 ↗
36. 10.1016/S0735-1097(96)00584-010.1016/S0735-1097(96)00584-0 ↗
37. 10.1007/BF0022580410.1007/BF00225804 ↗
38. 10.1016/S0141-3910(00)00102-610.1016/S0141-3910(00)00102-6 ↗
39. 10.1016/S0168-3659(00)00241-810.1016/S0168-3659(00)00241-8 ↗
40. 10.1021/bm030039710.1021/bm0300397 ↗
41. 10.4028/www.scientific.net/MSF.455-456.42910.4028/www.scientific.net/MSF.455-456.429 ↗
42. 10.1007/s10019000011210.1007/s100190000112 ↗
43. 10.1016/S0168-3659(01)00248-610.1016/S0168-3659(01)00248-6 ↗
44. 10.1021/js960411710.1021/js9604117 ↗
45. 10.1016/S0142-9612(03)00024-310.1016/S0142-9612(03)00024-3 ↗
46. 10.1016/S0142-9612(97)00221-410.1016/S0142-9612(97)00221-4 ↗
47. 10.1016/0142-9612(84)90063-210.1016/0142-9612(84)90063-2 ↗
48. 10.1002/jbm.82029060810.1002/jbm.820290608 ↗
49. 10.1016/S0144-8617(01)00263-610.1016/S0144-8617(01)00263-6 ↗
50. 10.1016/S0168-3659(97)00050-310.1016/S0168-3659(97)00050-3 ↗
51. 10.1016/S0142-9612(03)00413-710.1016/S0142-9612(03)00413-7 ↗
52. 10.1016/0378-5173(95)00128-610.1016/0378-5173(95)00128-6 ↗